PROJECT

Projects

Summary of Investment Information

Project Number

48756

Company Name

Joincare Pharmaceutical Group Industry Co., Ltd.

Date SPI Disclosed

Nov 19, 2024

Country

China

Region

East Asia and the Pacific

Projected Board Date

Dec 19, 2023

Environmental Category

B - Limited

Status

Active

Last Updated Date

Nov 20, 2024

Department

Regional Industry - MAS Asia & Pac

Industry

other

Previous Events

Approved : Dec 19, 2023
Signed : Jan 29, 2024
Invested : Jul 11, 2024

Sector

other

Project Description

Founded in 1992 and headquartered in Shenzhen, Joincare Pharmaceutical Group Industry Co., Ltd. (“Joincare”, “Company”) is a diversified pharmaceutical manufacturer of chemical drugs, active pharmaceutical ingredient and intermediates, biological drugs and diagnostic reagents and equipment.

The proposed investment will support Joincare to fund: (i) the expansion for development and production capacity of APIs and finished formulations in Henan and Guangdong provinces, China; and (ii) investment, including working capital needs, related to key therapeutic areas (together, the “Project”). The additional production capacity created by the Project will enable the Company, given its vertical integration and scale, to produce APIs and intermediates at lower cost and improve the affordability and availability of pharmaceutical products in China and in emerging markets.

Sponsor / Cost / Location

Development Impact

E&S Category Rationale / Risks and Mitigation